Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s stock price rose 10.2% during mid-day trading on Tuesday . The company traded as high as C$0.28 and last traded at C$0.27. Approximately 223,000 shares were traded during mid-day trading, an increase of 115% from the average daily volume of 103,522 shares. The stock had previously closed at C$0.25.
Theralase Technologies Stock Up 1.9 %
The firm has a market capitalization of C$67.52 million, a PE ratio of -13.75 and a beta of 1.36. The stock has a 50-day simple moving average of C$0.27 and a 200-day simple moving average of C$0.23. The company has a quick ratio of 3.40, a current ratio of 1.21 and a debt-to-equity ratio of 20.58.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Articles
- Five stocks we like better than Theralase Technologies
- What Does Downgrade Mean in Investing?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Canada Bond Market Holiday: How to Invest and Trade
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
